Ongoing clinical studies would be promising in the search for a vaccine against Lyme disease, according to microbiologist and infectious disease specialist Alex Carignan. The first tests show the development of antibodies in volunteers, and the vaccine seems safe, according to the one who is also a professor at the Faculty of Medicine and Health Sciences at the University of Sherbrooke.
Large-scale trials are also beginning in the United States and Europe; the vaccine is being developed by Pfizer in collaboration with a French pharmaceutical company.
” The aim is to give three doses of vaccine in the first year. […] It is a vaccine that would be seasonal with a booster dose every spring, just before tick season. »
An effective treatment also exists, according to the microbiologist who encourages the population to consult as quickly as possible at the onset of the symptoms of the disease.
Alex Carignan points out that the risks are very present in Quebec, obviously in fairly affected regions such as Estrie or Montérégie, but also in others further north such as Saguenay–Lac-Saint-Jean.